BioWorld

April 25, 2005

View Archived Issues

Lifted By Higher Product Sales, Amgen Beats Consensus EPS

Beating Wall Street estimates, Amgen Inc. performed well in the first quarter, reporting strong revenue for most of its products, despite Medicare reimbursement changes. (BioWorld Today) Read More

Solexa Signs Deal To Raise $32.5M, Advance Platform

Read More

Novel Approach To Synthesis Causing Tetracycline Variety

Read More

Recent Stem Cell Bill Forbids Human Reproductive Cloning

Read More

Hamilton Pharmaceuticals' First Financing: $11M For CNS Drugs

Read More

Other News To Note

Read More